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Abstract
Background: Accurate information about prescribing patterns in hospitals is valuable in improving
the quality of antimicrobial prescriptions.
Methods:  Data on the use of antimicrobial agents in eighteen tertiary care hospitals were
collected on March 20th 2002.
Results: One or more antimicrobials were ordered in 2900 (30.6 %)of 9471 hospitalized patients.
The reasons of hospitalization of the patients receiving antimicrobials were medical treatment (42.5
%), elective surgery (39.6 %), treatment of infectious disease (17.1 %) and emergent surgical
procedures (10.4 %). The highest consumption frequencies were found in surgical (81.6 %) and
medical (55.2 %) intensive care units. The 48.8 % of antimicrobials were given for treatment and
44.2 % for prophylactic use. The most common reasons for treatment were found as lower
respiratory tract, urinary tract, surgical wound infections and febrile neutropenia. Antimicrobials
were ordered empirically in 78.4 % of patients. The proven infection ratio was found as 30.7 %. The
56.4 % and 13.4 % of orders were evaluated as clinically and microbiologically appropriate
respectively.
Conclusion: These results suggest that antimicrobial prescription and empirical treatment ratios
were high and inappropriate at inpatient groups.
Introduction
Since antimicrobial chemotherapy was introduced in
medical practice, there have been calls for its rational use.
Appropriate antimicrobial treatment greatly improves the
prognosis of infectious diseases. There has been a very sig-
nificant reduction in morbidity and mortality associated
with the use of antimicrobials since they were first intro-
duced [1]. However, the overuse of antimicrobials may
increase the risks of drug resistant pathogens, side effects
and costs of medical care. The right agent at the right dose
and dosing interval and right duration can achieve both a
favorable clinical outcome and prevent the selection of
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resistance. It was reported that 20–50% of antimicrobial
use in humans was questionable or inappropriate [1,2].
Accurate information about prescribing patterns in hospi-
tals is valuable in improving the quality of antimicrobial
prescriptions.
Only very limited data on the usage of antimicrobials in
Turkey [1,3]. The over use of antimicrobials increases the
risk of drug resistant pathogens, side affects and cost of
medical care [4]. This multicenter study was planned as a
point-prevalence study to evaluate antimicrobial prescrip-
tion frequency and patterns in tertiary care hospitals in
Turkey.
Materials and methods
This prospective study was conducted in eighteen tertiary
care hospitals from 14 different cities located in seven geo-
graphical regions of Turkey. These hospitals were repre-
senting approximately 30% of all tertiary care hospitals in
Turkey. Data on the use of antimicrobial agents in these
hospitals were collected by infectious diseases consultants
on March 20th 2002. The same methodology was used for
all hospitals. All patients who have received antimicrobi-
als for any reason were included to this study. The data
was included to the study within the first week of the
study day, if there was a delay in the recording of data for
any reason such as unavailable culture results which the
specimen for this culture was collected before or on March
20th 2002.
In the study, total bed capacities of hospitals, number of
hospitalized patients, the type and number of antimicro-
bial prescriptions, the main diagnosis which the prescrip-
tion was made, clinical and microbiological evidences for
treatment were recorded. The presence of an infectious
disease was diagnosed according to signs and symptoms,
non-microbiological and microbiological laboratory find-
ings and defined as proven infection.
For patients receiving antimicrobials, demographic data,
reason for admission and hospitalization, results of
microbiological samples, name and dosage of antimicro-
bials and indication for antimicrobials were recorded on
special forms. The antimicrobial regimes were evaluated
according to choice, combination, duration and dose of
the antimicrobials.
Hospital and patients details were recorded in two differ-
ent forms. The first one was for the hospital details such as
the name of the hospital, total bed capacity, departments
and their bed capacities, total number of hospitalized
patients of the hospital and of each department on the
study day. The second form was used for recording data of
patients which were receiving an antimicrobial agent on
the study day. All of the records were collected and evalu-
ated by the principal investigators in the study center. All
of the data was transferred to the computer using a file
designed by Dr. Ozgunes with Microsoft Access.
The antimicrobial prescription ratio, hospitalization rea-
son of antimicrobial receiving patients and combination
therapies were evaluated. Antimicrobial prescriptions
were globally considered inappropriate if any of the
assessed criteria appeared unacceptable, according to indi-
cation or antimicrobial choice, dosage errors, and dura-
tion of treatment. Appropriateness of antimicrobial
prescriptions was evaluated according to the clinical and
laboratory findings on the beginning of the therapy.
Statistical analyses were made by chi square test.
Results
Eighteen tertiary care hospitals from 14 different cities of
Turkey included to the study. 9471 hospitalized patients
were evaluated. One or more antimicrobials were ordered
in 2900(30.6%) of 9471 patients. In the antimicrobial
receiving group 1232 (42.5 %) patients were hospitalized
for medical treatment, 1147 (39.6%) for elective surgery,
497(17.1%) for infectious diseases, 303 (10.4 %) for
emergent surgery and 73(2.5%) for other reasons. There
were more than one hospitalization reasons for some
patients (Table 1).
The highest antimicrobial consumption ratios were found
in intensive care units (ICU) (Surgical ICU 81%, medical
ICU 52.5%). Antimicrobial consumption frequencies
according to departments (surgical/medical) were shown
in table 2.
The indications of antimicrobial therapy were also evalu-
ated. The 48.8 % of antimicrobials were given for treat-
Table 1: Hospitalized, antimicrobial receiving patients and 
hospitalization reasons of antimicrobial prescribed patients in 18 
centers.
n%
Hospitalized patients 9471 100
Antimicrobial receiving patients 2900 30.6
Hospitalization reason
Medical treatment 1231 42.5
Elective surgery 1147 39.6
Treatment of an infectious diseases 497 17.1
Emergent surgery 303 10.4
Other reasons 73 2.5Annals of Clinical Microbiology and Antimicrobials 2005, 4:16 http://www.ann-clinmicrob.com/content/4/1/16
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ment of an infectious disease and 44.2 % for surgical
antimicrobial prophylaxis. It wasn't found any reason for
antimicrobial prescriptions in 204 (7 %) patients' records.
More than one reason was reported for some patients.
Antimicrobial prescriptions were made empirically in
2275 (78.4 %) of patients and according to microbiologi-
cal data in 334 (11.5%).
The proven infection ratio was found as 30.7 % in 2900
patients and 57.15% (807 of 1412) in treatment group.
The antimicrobial prescriptions were evaluated by the
investigator if or not they were appropriate to clinical and
microbiological data. The 56.4 % and 13.4 % of orders
were evaluated as clinically and microbiologically appro-
priate respectively in 2900 patients. In patients receiving
prophylactic antimicrobials 671(52.46%) of 1279
prescription were evaluated as appropriate (Table 3). The
61.54% (869 of 1412) prescriptions were evaluated as
clinically appropriate in patients receiving antimicrobials
for treatment (Table 3). There was not any microbiologi-
cal data in 986 (69.83%) patients in this group. The
microbiologically appropriate prescription ratio was
found 84.04% in 326 patients with microbiological data.
The appropriate and inappropriate prescription in treat-
ment group was given in table 3.
The combination therapy ratio was found as 33%. 50
patients including tuberculosis cases were receiving more
than three antimicrobials. 25 patients were receiving com-
Table 2: The distribution of antimicrobial prescribed patients to hospitalized patients.
Antimicrobial prescribed Total hospitalized Percentage of antimicrobial 
prescribed
Surgical Clinics 1414 4172 33.9%*
Medical Clinics 1138 4529 25.1%*
Surgical ICU 107 132 81%*
Medical ICU 83 158 52.5%*
Total 2900** 9471 30.6%*
ICU: Intensive care unit.
*The ratios were found statistically different (x2 = 119 SD = 2, P < 0.001).
**The wards of 158 patients were not reported.
Table 3: The appropriate prescription in patients receiving prophylactic antimicrobials and the proven infection, clinically and 
microbiologically appropriate treatment ratios in patients that were treated for an infection.
n%
Prophylactic antimicrobial use Appropriate 671 52.46*
Inappropriate 423 33.07*
Not reported 185 14.46
TOTAL 1279
Clinically Proven infection 807 57.15
Appropriate 869 61.54**
Inappropriate 364 25.77**
Not reported 179 12.67
TOTAL 1412 100
Microbiologically Appropriate 274 84.04***
Inappropriate 52 15.95***
Not reported 88 6.23
TOTAL 414**** 100
No microbiological data 986 69.83
*t = 9.91, SD = 1092, p < 0.00
**t = 19.16, SD = 1231, p < 0.001
*** t = 15.79, SD = 324, p < 0.001
****The microbiological data was not available for all patients.Annals of Clinical Microbiology and Antimicrobials 2005, 4:16 http://www.ann-clinmicrob.com/content/4/1/16
Page 4 of 5
(page number not for citation purposes)
bination therapy because of tuberculosis. 453 (15.6 %) of
patients were receiving three antimicrobials and 428 of
them (14.7%) were non-tuberculosis patients.
The most common prescribed antibiotics were cefazolin,
ampicillin-sulbactam, ceftriaxone, ciprofloxacin, ami-
kacin, gentamicin, ornidazole, cefuroxime, meropenem
and vancomycin. The prescription ratios of antibiotic
groups were given in table 4.
The most common used antibiotics in combinations were
aminoglycosides (30.8%), 3rd generation cephalosporins
(21.1%), penicillins (18,8%), ornidazole-metronidazol-
clindamycin (18.2%), glicopolypeptides (13.1%), qui-
nolones (11.9%) and carbapenems (10.9%) (Table 4).
The 88.5% of combined aminoglycosides were used in
combination with beta-lactams and glycopolypeptides.
There were 15 combinations of sulbactam-ampicillin with
clindamycin, ornidazole or metronidazol. We determined
that 67.44 % of the patients were in official health insur-
ance systems and 19.7 % of them were in official social
assistance system.
Discussion
Although the principles of rational antimicrobial usage
have been well defined for many years, inappropriate use
of antimicrobials remains wide spread. The cost, adverse
effects and development of resistance are main problems
in wide spread usage of antimicrobials. The emergence
and spread of drug resistant pathogens have already
become a very serious problem internationally. It was
reported that 14% and 43% of all courses of antimicrobial
chemotherapy were deemed unnecessary because there
was no evidence of infection [2,5,6].
In this study, antimicrobial prescription frequency was
found as 30.6% in hospitalized patients. The antibiotic
prescription frequency was reported as 77.8% from a uni-
versity hospital in China, and as 65% from a pediatric
teaching in Costa Rica [6,7]. Empirical antimicrobial pre-
scription and combination antimicrobial treatment ratios
were high (78.4%, 33%) in the study group also. The
problem is more serious in ICU and surgical departments
than medical departments. The antimicrobial prescription
ratios were higher in ICU's (81% of surgical ICU, 52.5%
of medical ICU) than other departments of hospitals (P <
0.001). It was reported that the 58.0% of surgical ICU
patients in a university hospital from Germany were
receiving antibiotics [8]. The antibiotic prescription fre-
quency was reported as 6.55 and 14.4% from two differ-
ent pediatric ICUs from Israel [9]. The proven infection
ratio was found as 30.7% in the appropriate antimicrobial
treatment given group and 57.9% in the inappropriate
antimicrobial treatment group. The results of the study
showed that inappropriate antimicrobial prescription was
an obvious problem in the study hospitals of Turkey.
More than 40 % of antimicrobial prescriptions were made
without a proven infection. Inappropriate antimicrobial
usage is a worldwide problem. 40% of antibiotic prescrip-
tions were reported that had no record of justification and
55% of prescriptions had no indication of planned dura-
tion of therapy [7].
The 44% of antimicrobial prescriptions were made for
surgical prophylaxis and 52.4% of them were appropriate.
This group was seemed to be increasing the inappropriate
prescription ratios because of the long duration usage and
wrong selection of antimicrobials. Hu et al reported that
30% of hospitalized patients were receiving perioperative
antibiotics and 20% of them received antibiotics before or
Table 4: The most common prescribed antibiotic groups in hospitalized patients and the most common used antibiotics in 
combinations.
Antibiotic group Prescription % Combination %
Penicillines 23.6 18.8
1.Generation Cephalosporins 14.6 7.1
2.Generation Cephalosporins 5.3 0.0
3.Generation Cephalosporins 23.7 21.1
4.Generation Cephalosporin 4.2 4.5
Aminoglycosides (Excluding streptomycin) 17.2 30.8
Carbapenems 6.5 10.9
Glycopolypeptides 4.8 13.1
Ornidazole-Metronidazole-Clindamycin 9.9 18.2
Quinolones 14.4 11.9
Macrolides 3.0 4.7
Tetracyclines 0.7 1.2
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during operation and 80% of them after operation. The
duration of perioperative antibiotic prophylaxis was less
than or equal to seven days in 42.7% of patients, 8–13
days in 31%, and 14 days or more in 26.3% [6]. In
another study reported by Bailly et al, the rate of compli-
ant prescription for surgical prophylaxis was 41.7% [10].
Also the combination therapy ratios were found as high as
33% of total antimicrobial prescribed patients. It can be
thought that there is a relation between high empirical
antimicrobial treatment and high combination therapy
ratios. The limited microbiological evidence for the diag-
nosis of infection can be thought as another reason for
high ratios of empirical and combination therapies
because of the microbiologically appropriate and inap-
propriate usage ratios were found as 84.04% and 15.95%
respectively in the treatment group. These results suggest
that a multidisciplinary antimicrobial management sys-
tem is required in hospitals because of the high propor-
tion of empirically treatment and inappropriate use of
antimicrobials. The system must have legal support and
the antimicrobial control teams must be include the
departments of infectious diseases, microbiology, phar-
macy, and infection control [1]. Also there is need good
microbiological support for clinicians to increase the
appropriate prescription rate. Local and practical antimi-
crobial treatment guidelines for clinicians and continuous
education programs may decrease the inappropriate,
empirical and combination therapy ratios.
The cost of antimicrobials is another serious problem for
insurance systems in Turkey. The anti-infective drugs are
the most used drugs (22% of all drugs) in our country. The
annually antimicrobial and total drug cost for per person
was calculated as $8,4 and $38 in Turkey [11].
In conclusion, this point-prevalence study revealed that
more than 50% of patients received inappropriate antimi-
crobial prescriptions. We thought that only restricted pre-
scription procedures are not enough for the reduction of
inappropriate antimicrobial rates. A general antimicrobial
treatment program must include education, guidelines,
restricted usage, control of the hospital pharmacies and
automatic discontinuation by the hospital pharmacies.
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